Francis Tally and the Discovery and Development of Tigecycline: A Personal ReminiscencePROJAN, Steven J.Clinical infectious diseases. 2010, Vol 50, issn 1058-4838, S24-S25, SUP1Conference Paper

Tigecycline : A critical analysisSTEIN, Gary E; CRAIG, William A.Clinical infectious diseases. 2006, Vol 43, Num 4, pp 518-524, issn 1058-4838, 7 p.Article

Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysisTASINA, Efthimia; HAIDICH, Anna-Bettina; KOKKALI, Stamatia et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 11, pp 834-844, issn 1473-3099, 11 p.Article

Off-label prescription of tigecycline: clinical and microbiological characteristics and outcomesCONDE-ESTEVEZ, David; GRAU, Santiago; PABLO HORCAJADA, Juan et al.International journal of antimicrobial agents (Print). 2010, Vol 36, Num 5, pp 471-472, issn 0924-8579, 2 p.Article

High Concentrations of Manganese in Mueller-Hinton Agar Increase MICs of Tigecycline Determined by EtestFERNANDEZ-MAZARRASA, Carlos; MAZARRASA, Olav; CALVO, Jorge et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 3, pp 827-829, issn 0095-1137, 3 p.Article

The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)FARRELL, David J; TURNIDGE, John D; BELL, Jan et al.The Journal of infection. 2010, Vol 60, Num 6, pp 440-451, issn 0163-4453, 12 p.Article

Clinical Pharmacokinetics and Pharmacodynamics of TigecyclineBARBOUR, April; SCHMIDT, Stephan; MA, Benjamin et al.Clinical pharmacokinetics. 2009, Vol 48, Num 9, pp 575-584, issn 0312-5963, 10 p.Article

Functional, biophysical, and structural bases for antibacterial activity of tigecyclineOLSON, Matthew W; RUZIN, Alexey; FEYFANT, Eric et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 6, pp 2156-2166, issn 0066-4804, 11 p.Article

Tigecycline : A new glycylcycline for treatment of serious infectionsNOSKIN, Gary A.Clinical infectious diseases. 2005, Vol 41, Num 5, pp S303-S314, issn 1058-4838, SUPArticle

Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority TrialsPRASAD, Paritosh; JUNFENG SUN; DANNER, Robert L et al.Clinical infectious diseases. 2012, Vol 54, Num 12, pp 1699-1709, issn 1058-4838, 11 p.Article

Antimalarial Activity of Tigecycline, a Novel Glycylcycline AntibioticSTARZENGRUBER, P; THRIEMER, K; HAQUE, R et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 9, pp 4040-4042, issn 0066-4804, 3 p.Article

Tigecycline : what is it, and where should it be used?LIVERMORE, David M.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 4, pp 611-614, issn 0305-7453, 4 p.Article

Comparative Evaluation of Tigecycline Susceptibility Testing Methods for Expanded-Spectrum Cephalosporin- and Carbapenem-Resistant Gram-Negative PathogensZARKOTOU, Olympia; POURNARAS, Spyros; ALTOUVAS, George et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 11, pp 3747-3750, issn 0095-1137, 4 p.Article

Trends in the Susceptibility of Clinically Important Resistant Bacteria to Tigecycline: Results from the Tigecycline In Vitro Surveillance in Taiwan Study, 2006 to 2010CHEN, Yen-Hsu; LU, Po-Liang; JANG, Tsrang-Neng et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 3, pp 1452-1457, issn 0066-4804, 6 p.Article

Differences in Determining In Vitro Tigecycline Susceptibility According to the Agar Medium UsedLEAL, A. L; BUITRAGO, G; OVALLE, M. V et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 2, pp 137-138, issn 1120-009X, 2 p.Article

Evaluation of Etest To Determine Tigecycline MICs for Enterobacter SpeciesCOHEN STUART, James; MOUTON, Johan W; DIEDEREN, Bram M. W et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 6, pp 2746-2747, issn 0066-4804, 2 p.Article

Tigecycline : The answer to beta-lactam and fluoroquinolone resistance?FRAISE, Adam P.The Journal of infection. 2006, Vol 53, Num 5, pp 293-300, issn 0163-4453, 8 p.Article

Peritoneal fluid penetration of tigecyclineSCHEETZ, Marc H; REDDY, Pavani; NICOLAU, David P et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 11, pp 2064-2067, issn 1060-0280, 4 p.Article

TigecyclinePANKEY, George A.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 3, pp 470-480, issn 0305-7453, 11 p.Article

Variation in Potency and Spectrum of Tigecycline Activity against Bacterial Strains from U.S. Medical Centers since Its Approval for Clinical Use (2006 to 2012)SADER, Helio S; FARRELL, David J; FLAMM, Robert K et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 4, pp 2274-2280, issn 0066-4804, 7 p.Article

AdeRS combination codes differentiate the response to efflux pump inhibitors in tigecycline-resistant isolates of extensively drug-resistant Acinetobacter baumanniiSUN, J.-R; PERNG, C.-L; LIN, J.-C et al.European journal of clinical microbiology & infectious diseases (Print). 2014, Vol 33, Num 12, pp 2141-2147, issn 0934-9723, 7 p.Article

Ineffectiveness of Tigecycline against Persistent Borrelia burgdorferiBARTHOLD, Stephen W; HODZIC, Emir; IMAI, Denise M et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 2, pp 643-651, issn 0066-4804, 9 p.Article

Influence of Media and Testing Methodology on Susceptibility to Tigecycline of Enterobacteriaceae with Reported High Tigecycline MICTORRICO, M; GONZALEZ, N; GIMENEZ, M. J et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 6, pp 2243-2246, issn 0095-1137, 4 p.Article

Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella sppCAPOOR, Malini R; NAIR, Deepthi; POSTI, Jitendra et al.Journal of medical microbiology. 2009, Vol 58, Num 3, pp 337-341, issn 0022-2615, 5 p.Article

Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenesSALAS, Carlos; CALVO, Jorge; MARTINEZ-MARTINEZ, Luis et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 4, pp 1503-1505, issn 0066-4804, 3 p.Article